Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
28 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


RSS FeedsHalf of lymphoma patients alive three years after Gilead cell therapy treatment: study
(Reuters Health)

 
 

8 december 2019 05:06:24

 
Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
(Reuters Health)
 
Nearly half of lymphoma patients treated with Gilead Sciences Inc`s Yescarta were alive at least three years after a one-time infusion of the CAR-T cell therapy, according to data presented on Saturday.


 
13 viewsCategory: Science > Medicine
 
Gibson, No. 16 Memphis top No. 21 Cincinnati for AAC title
(WorldNews Health)
Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal
(Reuters Health)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten